In the field of Regenerative Medicine, the preclinical and clinical research on multipotent adult stem cells, and in ...
Thepatent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, peripheral ...
PrimeGen US and DT Cloud Star Acquisition have entered a definitive merger agreement at an implied equity value of around $1.5bn.
Explore the vital role of bone marrow stem cells. Learn how they drive bone remodeling, immunity, and skeletal health in this complete guide.
Access the “What This Means” segment here CAMBRIDGE, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ...
Longeveron receives Japanese patent for potency assay methods to assess human mesenchymal stem cells
Longeveron receives Japanese patent for potency assay methods to assess human mesenchymal stem cells: Miami Saturday, January 31, 2026, 13:00 Hrs [IST] Longeveron Inc, a clinical ...
Stem cell therapy biotech PrimeGen US is taking the less-traveled special purpose acquisition company (SPAC) route to the ...
A first-in-human pilot trial suggests umbilical cord–derived mesenchymal stem cell eye drops may safely improve symptoms and ...
Publicly traded special purpose acquisition company DT Cloud Star Acquisition is set to acquire biotech company PrimeGen US, taking the company public.
TAM Global announced today the publication of a peer-reviewed study demonstrating that commercially available Wharton's jelly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results